Statistics on Biotechnology Use Results by sector of operation Sector Companies. Results in biotechnology for main variables and branches of activity Unidades: specified in variables Total Companies Services Industry and Construction Agriculture No. of companies carrying out R&D in Biotechnology 1.133 722 333 79 %Companies according to biotechnology used: Genetic code 33 40 19 32 %Companies according to biotechnology used: Functional units 41 45 38 23 %Companies according to biotechnology used: Cellular and tissue culturing and engineering 24 28 15 26 %Companies according to biotechnology used: Bioprocesses 50 39 76 35 %Companies according to biotechnology used: Sub-cellular organisms 6 8 2 0 %Companies according to biotechnology used: Bio-computing 24 33 9 11 %Companies according to biotechnology used: Nanobiotechnology 13 16 8 4 %Companies according to biotechnology used: Other 14 16 8 30 Companies in which biotechnology activities are: Main and/or exclusive 603 490 99 15 Companies in which biotechnology activities are: A secondary line of business 173 97 60 16 Companies in which biotechnology activities are: A tool necessary for production 357 135 175 48 %Company by field(s) of ultimate application of biotechnology use: Human Health 45 59 24 6 %Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture 18 20 11 27 %Company by field(s) of ultimate application of biotechnology use: Food products 31 23 51 23 %Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production 22 20 18 62 %Company by field(s) of ultimate application of biotechnology use: Environment 14 13 15 14 %Company by field(s) of ultimate application of biotechnology use: Industry 12 14 12 1 Personnel in R&D in biotechnology (no. of persons) 11.510 7.769 3.054 687 Personnel in R&D in biotechnology (no. of persons): Researchers 6.202 4.554 1.408 241 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants 5.308 3.215 1.646 446 Personnel in R&D in biotechnology (no. of persons): women 6.389 4.518 1.543 328 Personnel in R&D in biotechnology (no. of persons): (women) Researchers 3.304 2.434 754 115 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants 3.086 2.084 789 213 Personnel in R&D in biotechnology (FTE) 8.236,9 5.941,7 1.868,5 426,7 Personnel in R&D in biotechnology (FTE): Researchers 4.596,1 3.468,7 963,3 164,1 Personnel in R&D in biotechnology (FTE): Technicians and assistants 3.640,8 2.473 905,3 262,6 Personnel in R&D in biotechnology (FTE): women 4.698,5 3.453 1.020,7 224,9 Personnel in R&D in biotechnology (FTE): (women) Researchers 2.512,5 1.878,4 557,4 76,6 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants 2.186 1.574,5 463,3 148,2 Internal expenditure on R&D (thousands of euros) 769.431 533.657 201.922 33.852 1) By nature of the expense: Current expenses 719.715 504.270 185.577 29.868 1.1) Remuneration to researchers 221.447 149.223 64.648 7.576 1.2) Remuneration to technicians and assistants 122.809 75.033 41.097 6.679 1.3) Other current expenses 375.459 280.014 79.832 15.614 2) By nature of the expense: Capital expenses 49.715 29.387 16.345 3.984 2.1) Land and buildings 9.521 3.329 4.506 1.687 2.2) Equipment and instruments 30.466 18.712 9.484 2.269 2.3) Acquisition of specific R&D software 1.810 1.279 508 23 2.4) Otros productos de propiedad intelectual específicos para I+D 7.919 6.066 1.847 5 1.1) By origin of the funds: Own funds 490.913 304.305 156.340 30.268 1.2) By origin of the funds: From companies 82.548 76.853 5.695 0 1.3) By origin of the funds: Public Administration funds 96.809 83.993 11.520 1.296 1.4) By origin of the funds: From Universities 197 185 12 0 1.5) By origin of the funds: From non profit private institutions 4.766 4.766 0 0 1.6) By origin of the funds: Foreign funds 94.197 63.555 28.355 2.288 Purchase of R&D services in biotechnology (thousands of euros) 120.281 60.387 59.506 389 Purchase of R&D services in biotechnology (thousands of euros): In Spain 69.564 15.873 53.360 331 Purchase of R&D services in biotechnology (thousands of euros): Abroad 50.718 44.514 6.146 58 %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital 45 54 27 41 %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information 12 11 16 13 %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources 16 16 16 15 %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain 14 15 12 9 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets 16 19 11 14 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels 18 21 13 14 %Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception 15 16 13 20 %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements 37 38 33 37 %Companies that consider the following obstacles as very important considering biotechnology development: Time / cost 52 56 42 57 %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting 20 21 15 29 % Companies that have requested biotechnology patents in Biotechnology 15 17 11 6 Number of patents requested 681 493 154 34 % Companies with income of an international origin related to biotechnological activities 24,3 29 18,4 6,4 % Turnover representing income of an international origin related to biotechnological activities 1 4 1 0 % Income of an international origin related to biotechnological activities distributed in: Income received from the EU 59,6 46,8 62,9 94,5 % Income of an international origin related to biotechnological activities distributed in: Income received from other countries 40,4 53,2 37,1 5,5 % Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services 80,4 69,2 83,4 99,3 % Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain 16,5 17 16,4 0 % Income of an international origin related with activities according to the classification: Operating source abroad 2,2 9,7 0,2 0,7 % Income of an international origin related with activities according to the classification: Other 0,9 4,1 0 0 Notas: '.'=numeric piece of data equal to zero not resulting from rounding FTE: Full Time Equivalent Fuente: National Statistics Institute